Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | daunorubicin | 30323 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | daunorubicin | 30323 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | daunorubicin | 30323 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | daunorubicin | 30323 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | daunorubicin | 30323 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | daunorubicin | 30323 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | daunorubicin | 30323 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | daunorubicin | 30323 | drug-path |
| PPAR signaling pathway | R-HSA-168638 | map03320 | daunorubicin | 30323 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | daunorubicin | 30323 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | daunorubicin | 30323 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | daunorubicin | 30323 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | daunorubicin | 30323 | drug-path |
| Shigellosis | 0 | map05131 | daunorubicin | 30323 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | daunorubicin | 30323 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | daunorubicin | 30323 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | daunorubicin | 30323 | drug-path |
| Primary immunodeficiency | R-HSA-5601905 | map05340 | daunorubicin | 30323 | drug-path |
| Regulation of autophagy | R-HSA-9612973 | 0 | daunorubicin | 30323 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | daunorubicin | 30323 | drug-path |